Your browser doesn't support javascript.
loading
Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial.
Herbert, K E; Demosthenous, L; Wiesner, G; Link, E; Westerman, D A; Came, N; Ritchie, D S; Harrison, S; Seymour, J F; Prince, H M.
Affiliation
  • Herbert KE; Department of Haematology, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, Victoria, Australia.
  • Demosthenous L; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
  • Wiesner G; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
  • Link E; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
  • Westerman DA; Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
  • Came N; Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
  • Ritchie DS; 1] Department of Haematology, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, Victoria, Australia [2] Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australia.
  • Harrison S; 1] Department of Haematology, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, Victoria, Australia [2] Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australia.
  • Seymour JF; 1] Department of Haematology, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, Victoria, Australia [2] Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australia.
  • Prince HM; 1] Department of Haematology, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, Victoria, Australia [2] Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australia.
Bone Marrow Transplant ; 49(8): 1056-62, 2014 Aug.
Article in En | MEDLINE | ID: mdl-24887382
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Granulocyte Colony-Stimulating Factor / Anti-HIV Agents / Hematopoietic Stem Cell Mobilization / Peripheral Blood Stem Cell Transplantation / Heterocyclic Compounds / Lymphoma / Multiple Myeloma Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2014 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Granulocyte Colony-Stimulating Factor / Anti-HIV Agents / Hematopoietic Stem Cell Mobilization / Peripheral Blood Stem Cell Transplantation / Heterocyclic Compounds / Lymphoma / Multiple Myeloma Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2014 Document type: Article